Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)

Clinical trial NCT01453725 · COMPLETED

Trial details

NCT number: NCT01453725
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spondylitis, Ankylosing

Start date: 2012-02-13
Primary completion: 2014-03-11
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.